This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood

Summary

The primary objective of this trial is to investigate whether and to what extent co-administration of multiple doses of itraconazole affect single dose pharmacokinetics of BI1015550, i.e. to compare the relative bioavailability of 6 mg BI 1015550 when given alone (reference, treatment R) to the relative bioavailability of 6 mg of BI 1015550 given on the 4th day of a 12-day-treatment with itraconazole (test, treatment T) following oral administration in healthy male subjects.

Timeline

Start

2018-05-03

Primary completion

2018-07-20

Completion

2018-07-20

Drugs

Indications

No indication recorded.